. Psy,

F. Hauts-de,

E. C. Johnstone, C. D. Frith, T. J. Crow, J. Husband, and L. Kreel, Cerebral ventricular size and cognitive impairment in chronic schizophrenia, The Lancet, vol.308, issue.7992, pp.924-950, 1976.

. Info-radiologie, Disponible sur

, Collège des enseignants de radiologie de France. Imagerie médicale, Radiologie et médecine nucléaire, 2015.

L. Minor, J. M. Dillenseger, and J. , Neuroanatomie descriptive: Cours, atlas pratique et clés pour l'imagerie médicale, 2019.

J. Tang, Y. Liao, B. Zhou, C. Tan, W. Liu et al., Decrease in Temporal Gyrus Gray Matter Volume in First-Episode, Early Onset Schizophrenia: An MRI Study, PLoS ONE, vol.7, p.40247, 2012.

T. Takahashi, S. J. Wood, B. Soulsby, P. D. Mcgorry, R. Tanino et al., Follow-up MRI study of the insular cortex in first-episode psychosis and chronic schizophrenia

, Schizophrenia Research, vol.108, issue.1-3, pp.49-56, 2009.

Y. Takayanagi, T. Takahashi, L. Orikabe, N. Masuda, Y. Mozue et al.,

, Volume Reduction and Altered Sulco-Gyral Pattern of the Orbitofrontal Cortex in First-Episode Schizophrenia, Schizophrenia Research, vol.121, issue.1-3, pp.55-65, 2010.

P. B. Mahon, H. Eldridge, B. Crocker, L. Notes, H. Gindes et al., An MRI Study of Amygdala in Schizophrenia and Psychotic Bipolar Disorder, Schizophrenia Research, vol.138, issue.2-3, pp.188-91, 2012.

D. R. Watson, F. Bai, S. L. Barrett, A. Turkington, T. M. Rushe et al.,

, Structural changes in the hippocampus and amygdala at first episode of psychosis, Brain Imaging and Behavior, vol.6, issue.1, pp.49-60, 2012.

C. Gourier-frery, C. Chee, C. Beltzer, and N. , Prévalence de la schizophrénie et autres troubles psychotiques en France métropolitaine, European Psychiatry, vol.29, issue.8, p.625, 2014.

S. Andor, A. Theodoridou, R. Schneider, and P. Et-conus, Premier épisode psychotique: un défi particulier pour le diagnostic différentiel et le traitement, Forum Med Suisse, 2012.

N. Franck and T. F. Hallucinations, Encyclopédie Médico-Chirurgicale, 2003.

A. A. Houle, C. Bacque-dion, R. Pauzé, and J. Lepage,

D. Rasic, T. Hajek, A. M. Uher, and R. , Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder and major depressive disorder : a meta-analysis of family hish-risk studies, prévalence, recension des écrits sur les facteurs de risque associés et les conséquences possibles sur les patients et leur famille, vol.40, pp.28-38, 2014.

K. Nakamura, T. Takahashi, K. Nemoto, A. Furuichi, S. Nishiyama et al.,

, Gray Matter Changes in Subjects at High Risk for Developing Psychosis and First-Episode Schizophrenia: A Voxel-Based Structural MRI Study, Frontiers in Psychiatry, vol.4, 2013.

V. M. Goghari, S. R. Sponheim, and A. W. Macdonald, The functional neuroanatomy of symptom dimensions in schizophrenia: A qualitative and quantitative review of a persistent question, Neuroscience & Biobehavioral Reviews, vol.34, issue.3, pp.468-86, 2010.

W. Y. Chan, G. L. Yang, M. Y. Chia, I. Y. Lau, Y. Y. Sitoh et al., White matter abnormalities in first-episode schizophrenia: A combined structural MRI and DTI study

, Schizophrenia Research, vol.119, issue.1-3, pp.52-60, 2010.

R. Jardri, A. Pouchet, D. Pins, and P. Thomas, Cortical activations during auditory verbal hallucinations in schizophrenia: a coordinate-based meta-analysis, The American Journal of Psychiatry, vol.168, issue.1, pp.73-81, 2011.

T. Fovet, A. Amad, T. Danel, P. Thomas, and R. Jardri,

, Santé Mentale, issue.179, pp.50-55, 2013.

A. Fornito, J. Yoon, A. Zalesky, E. T. Bullmore, and C. S. Carter, General and Specific Functional Connectivity Disturbances in First-Episode Schizophrenia During Cognitive Control Performance, Biological Psychiatry, vol.70, issue.1, pp.64-72, 2011.

M. J. Minzenberg, A. R. Laird, S. Thelen, C. S. Carter, and D. C. Glahn, , p.41

, Functional Neuroimaging Studies of Executive Function in Schizophrenia, Archives of General Psychiatry, vol.66, issue.8, pp.811-833, 2009.

R. Coentre, A. Silva-dos-santos, and M. C. Talina, Retrospective Study on Structural Neuroimaging in First-Episode Psychosis, PeerJ, vol.4, 2016.

, Les patients suivis en psychiatrie

P. Fusar-poli and A. Meyer-lindenberg, Forty Years of Structural Imaging in Psychosis: Promises and Truth, Acta Psychiatrica Scandinavica, vol.134, issue.3, pp.207-231, 2016.

O. Freudenreich, S. C. Schulz, and D. C. Goff, Initial Medical Work-up of First-Episode Psychosis: A Conceptual Review. Early Intervention in Psychiatry, vol.3, pp.10-18, 2009.

P. Mikolas, J. Hlinka, A. Skoch, Z. Pitra, T. Frodl et al., Machine Learning Classification of First-Episode Schizophrenia Spectrum Disorders and Controls Using Whole Brain White Matter Fractional Anisotropy, BMC Psychiatry, vol.18, issue.1, p.97, 2018.

X. Lu, Y. Yang, F. Wu, M. Gao, Y. Xu et al., Discriminative analysis of schizophrenia using support vector machine and recursive feature elimination on structural MRI images, Medicine, issue.30, p.95, 2016.

D. R. Watson, J. Anderson, F. Bai, S. L. Barrett, T. M. Mcginnity et al.,

, A Voxel Based Morphometry Study Investigating Brain Structural Changes in First Episode Psychosis, Behavioural Brain Research, vol.227, issue.1, pp.91-99, 2012.

I. Falkenberg, S. Benetti, M. Raffin, P. Wuyts, W. Pettersson-yeo et al.,

, Clinical Utility of Magnetic Resonance Imaging in First-Episode Psychosis, British Journal of Psychiatry, vol.211, issue.4, pp.231-268, 2017.

P. Castro-manglano, A. Mechelli, C. Soutullo, I. Landecho, and J. M. Gimenez-amaya,

F. Ortuño, Structural Brain Abnormalities in First-Episode Psychosis: Differences between Affective Psychoses and Schizophrenia and Relationship to Clinical Outcome: Volume Changes in First Affective Psychoses, Bipolar Disorders, vol.13, issue.5-6, pp.545-55, 2011.

P. Fusar-poli, S. Borgwardt, A. Crescini, G. Deste, M. J. Kempton et al.,

, Neuroanatomy of Vulnerability to Psychosis: A Voxel-Based Meta-Analysis, Neuroscience & Biobehavioral Reviews, vol.35, issue.5, pp.1175-85, 2011.

P. R. Szeszko, K. L. Narr, O. R. Phillips, J. Mccormack, S. Sevy et al.,

, Magnetic Resonance Imaging Predictors of Treatment Response in First-Episode Schizophrenia, Schizophrenia Bulletin, vol.38, issue.3, pp.569-78, 2012.

H. Autorité-de-santé,

M. Haute-autorité-de-santé-;-penttilä, E. Jääskeläinen, M. Haapea, P. Tanskanen, J. Veijola et al., Association between Duration of Untreated Psychosis and Brain Morphology in Schizophrenia within the Northern Finland, Birth Cohort. Schizophrenia Research, 1966.

T. Takahashi, S. J. Wood, B. Soulsby, Y. Kawasaki, P. D. Mcgorry et al., An MRI Study of the Superior Temporal Subregions in First-Episode Patients with Various Psychotic Disorders, Schizophrenia Research, vol.113, issue.2-3, pp.158-66, 2009.

H. Witthaus, C. Kaufmann, G. Bohner, S. Ozgürdal, Y. Gudlowski et al., Gray Matter Abnormalities in Subjects at Ultra-High Risk for Schizophrenia and First-Episode Schizophrenic Patients Compared to Healthy Controls, Psychiatry Research, vol.173, issue.3, pp.163-69, 2009.

T. Takahashi, S. J. Wood, B. Soulsby, R. Tanino, M. Wong et al.,

, Diagnostic Specificity of the Insular Cortex Abnormalities in First-Episode Psychotic Disorders, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.33, issue.4, pp.651-57, 2009.

P. Fusar-poli, R. Smieskova, G. Serafini, P. Politi, and S. Et-borgwardt, Neuroanatomical Markers of Genetic Liability to Psychosis and First Episode Psychosis: A Voxelwise Meta-Analytical Comparison, The World Journal of Biological Psychiatry, vol.15, issue.3, pp.219-247, 2014.

M. Chang, F. Y. Womer, E. K. Edmiston, C. Bai, Q. Zhou et al., Neurobiological Commonalities and Distinctions Among Three Major Psychiatric Diagnostic Categories: A Structural MRI Study, Schizophrenia Bulletin, vol.44, issue.1, pp.65-74, 2018.

A. Mané, C. Falcon, J. J. Mateos, E. Fernandez-egea, G. Horga et al.,

, Progressive Gray Matter Changes in First Episode Schizophrenia: A 4-Year Longitudinal Magnetic Resonance Study Using VBM, Schizophrenia Research, vol.114, pp.1-3, 2009.

M. J. Kempton, D. Stahl, S. Williams, and L. E. Et-delisi, Progressive Lateral Ventricular Enlargement in Schizophrenia: A Meta-Analysis of Longitudinal MRI Studies, Schizophrenia Research, vol.120, issue.1-3, pp.54-62, 2010.

R. Pérez-iglesias, D. Tordesillas-gutiérrez, G. J. Barker, P. K. Mcguire, and R. Roiz-santiañez,

I. Mata, White Matter Defects in First Episode Psychosis Patients: A Voxelwise Analysis of Diffusion Tensor Imaging, NeuroImage, vol.49, issue.1, pp.199-204, 2010.

M. Reis, T. H. Taylor, C. Chaddock, F. Dell'acqua, R. Handley et al.,

, White Matter Integrity as a Predictor of Response to Treatment in First Episode Psychosis, Brain, vol.137, issue.1, pp.172-82, 2014.

K. Cho, M. E. Shenton, M. Kubicki, W. H. Jung, T. Y. Lee et al.,

T. Connectivity, Probabilistic Tractography Study in Clinical-High Risk for Psychosis and First-Episode Psychosis, Schizophrenia Bulletin, 2016.

T. Melicher, J. Horacek, J. Hlinka, F. Spaniel, J. Tintera et al., White Matter Changes in First Episode Psychosis and Their Relation to the Size of Sample Studied: A DTI Study, Schizophrenia Research, vol.162, issue.1-3, pp.22-28, 2015.

T. Takahashi, S. Zhou, K. Nakamura, R. Tanino, A. Furuichi et al.,

, Longitudinal Volume Changes of the Pituitary Gland in Patients with Schizotypal Disorder and First-Episode Schizophrenia, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.35, issue.1, pp.177-83, 2011.

B. Garner, G. E. Berger, J. P. Nicolo, A. Mackinnon, S. J. Wood et al.,

, Pituitary Volume and Early Treatment Response in Drug-Naïve First-Episode Psychosis Patients, Schizophrenia Research, vol.113, issue.1, pp.65-71, 2009.

T. Takahashi, K. Nakamura, S. Nishiyama, A. Furuichi, E. Ikeda et al.,

, Increased Pituitary Volume in Subjects at Risk for Psychosis and Patients with First-Episode Schizophrenia: Pituitary Volume in Early Psychosis, Psychiatry and Clinical Neurosciences, vol.67, issue.7, pp.540-588, 2013.

P. Mcguire and P. Et-dazzan, Does Neuroimaging Have a Role in Predicting Outcomes in Psychosis ? World Psychiatry, vol.16, pp.209-219, 2017.

A. C. Altamura, G. Delvecchio, S. Paletta, D. Pace, C. Reggiori et al.,

, Gray Matter Volumes May Predict the Clinical Response to Paliperidone Palmitate Long-Acting in Acute Psychosis: A Pilot Longitudinal Neuroimaging Study, Psychiatry Research: Neuroimaging, vol.261, pp.80-84, 2017.

P. Dazzan, J. Mourao-miranda, A. Reinders, V. Rocha-rego, J. Lappin et al., Neuroimaging biomarkers to predict treatment response in schizophrenia: the end of 30 years of solitude?, Dialogues in Clinical Neuroscience, vol.16, issue.4, pp.491-503, 2014.

, Individualized Prediction of Illness Course at the First Psychotic Episode: A Support Vector Machine MRI Study, Psychological Medicine, vol.42, issue.5, pp.1037-1084, 2012.

N. Koutsouleris, S. Borgwardt, E. M. Meisenzahl, R. Bottlender, H. Möller et al.,

A. Riecher-rössler, Disease Prediction in the At-Risk Mental State for Psychosis Using Neuroanatomical Biomarkers: Results From the FePsy Study, Schizophrenia Bulletin, 2012.

K. O. Schubert, S. R. Clark, and B. T. Et-baune, The Use of Clinical and Biological Characteristics to Predict Outcome Following First Episode Psychosis, Australian & New Zealand Journal of Psychiatry, vol.49, issue.1, pp.24-35, 2015.

R. Jardri, Approches computationnelles de la schizophrénie, vol.202, pp.105-119, 2018.

N. Koutsouleris, R. S. Kahn, A. M. Chekroud, S. Leucht, P. Falkai et al.,

, Multisite Prediction of 4-Week and 52-Week Treatment Outcomes in Patients with First-Episode Psychosis: A Machine Learning Approach. The Lancet, Psychiatry, vol.3, issue.10, pp.935-981, 2016.

S. Borgwardt, P. Mcguire, and P. Et-fusar-poli, Gray Matters! -Mapping the Transition to

, Psychosis. Schizophrenia Research, vol.133, issue.1-3, pp.63-67, 2011.

T. Takahashi, S. J. Wood, A. R. Yung, B. Soulsby, and P. D. Mcgorry, Progressive Gray Matter Reduction of the Superior Temporal Gyrus during Transition to Psychosis, Archives of General Psychiatry, vol.66, issue.4, pp.366-76, 2009.

E. Zarogianni, A. J. Storkey, S. Borgwardt, R. Smieskova, E. Studerus et al., Individualized Prediction of Psychosis in Subjects with an At-Risk Mental State

, Schizophrenia Research, issue.17, pp.30537-30543, 2017.

N. Koutsouleris, S. Borgwardt, E. M. Meisenzahl, R. Bottlender, H. Möller et al.,

A. Riecher-rössler, Disease Prediction in the At-Risk Mental State for Psychosis Using Neuroanatomical Biomarkers: Results From the FePsy Study, Schizophrenia Bulletin, 2012.

E. Albon, A. Tsourapas, E. Frew, C. Davenport, F. Oyebode et al., Structural Neuroimaging in Psychosis: A Systematic Review and Economic Evaluation, Health Technology Assessment, vol.12, issue.18, p.163, 2008.

M. Yücel, N. Solowij, C. Respondek, S. Whittle, A. Fornito et al., Regional Brain Abnormalities Associated with Long-Term Heavy Cannabis Use, Archives of General Psychiatry, vol.65, issue.6, pp.694-701, 2008.

J. Radua, S. Borgwardt, A. Crescini, D. Mataix-cols, A. Meyer-lindenberg et al.,

. Pk, Multimodal Meta-Analysis of Structural and Functional Brain Changes in First Episode Psychosis and the Effects of Antipsychotic Medication, Neuroscience & Biobehavioral Reviews, vol.36, issue.10, pp.2325-2358, 2012.

, Annexe 2 : Trouble psychotique bref dans le DSM-5

A. , Présence d'un (ou plus) des symptômes suivants

, Discours désorganisé (p. ex. déraillements fréquents ou incohérence)

, Comportement grossièrement désorganisé ou catatonique

, Ne pas inclure un symptôme s'il s'agit d'une modalité de réaction culturellement admise

B. , Au cours d'un épisode, la perturbation persiste au moins un jour, mais moins d'un mois

C. , La perturbation n'est pas mieux expliquée par un trouble dépressif caractérisé ou bipolaire avec caractéristiques psychotiques, ou un autre trouble psychotique comme une schizophrénie ou une catatonie, et n'est pas due aux effets physiologiques d'une substance (p. ex. une substance donnant lieu à abus, un médicament) ou à une autre affection médicale

, Avec facteur(s) de stress marqué(s) (psychose réactionnelle brève) : Si les symptômes surviennent en réaction à des événements qui, isolément ou réunis, produiraient un stress marqué chez la plupart des sujets dans des circonstances similaires et dans la même culture

, Sans facteur(s) de stress marqué(s) : Si les symptômes ne surviennent pas en réaction à des événements qui, isolément ou réunis, produiraient un stress marqué chez la plupart des sujets dans des circonstances similaires et dans la même culture

, Avec début lors du post-partum : Si les symptômes surviennent durant la grossesse ou dans les 4 semaines du post-partum